These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22899340)

  • 81. The candidate immunotherapeutical target, the receptor for hyaluronic acid-mediated motility, is associated with proliferation and shows prognostic value in B-cell chronic lymphocytic leukemia.
    Giannopoulos K; Mertens D; Bühler A; Barth TF; Idler I; Möller P; Kröber A; Greiner J; Chocholska S; Dmoszyñska A; Roliñski J; Döhner H; Stilgenbauer S; Schmitt M
    Leukemia; 2009 Mar; 23(3):519-27. PubMed ID: 19092852
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Premalignant cell dynamics in indolent B-cell malignancies.
    Milpied P; Nadel B; Roulland S
    Curr Opin Hematol; 2015 Jul; 22(4):388-96. PubMed ID: 26049761
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Hodgkin's disease expressing follicular dendritic cell marker CD21 without any other B-cell marker: a clinicopathologic study of nine cases.
    Nakamura S; Nagahama M; Kagami Y; Yatabe Y; Takeuchi T; Kojima M; Motoori T; Suzuki R; Taji H; Ogura M; Mizoguchi Y; Okamoto M; Suzuki H; Oyama A; Seto M; Morishima Y; Koshikawa T; Takahashi T; Kurita S; Suchi T
    Am J Surg Pathol; 1999 Apr; 23(4):363-76. PubMed ID: 10199466
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Expression of CD21 in peripheral blood B lymphocytes of neonates].
    Zhang R; Wang QJ; Xu JM; Jiang L; Shou WZ; Yin Y
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Dec; 9(6):546-8. PubMed ID: 18082036
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Genetic Loss of LCK Kinase Leads to Acceleration of Chronic Lymphocytic Leukemia.
    Märklin M; Fuchs AR; Tandler C; Heitmann JS; Salih HR; Kauer J; Quintanilla-Martinez L; Wirths S; Kopp HG; Müller MR
    Front Immunol; 2020; 11():1995. PubMed ID: 32983140
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Uncontrolled CD21
    Masle-Farquhar E; Peters TJ; Miosge LA; Parish IA; Weigel C; Oakes CC; Reed JH; Goodnow CC
    Cell Rep; 2022 Jan; 38(3):110259. PubMed ID: 35045301
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Role of complement receptors CD21/CD35 in B lymphocyte activation and survival.
    Carroll M
    Curr Top Microbiol Immunol; 1999; 246():63-8; discussion 69. PubMed ID: 10396040
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Defining in vivo transcription factor complexes of the murine CD21 and CD23 genes.
    Debnath I; Roundy KM; Weis JJ; Weis JH
    J Immunol; 2007 Jun; 178(11):7139-50. PubMed ID: 17513763
    [TBL] [Abstract][Full Text] [Related]  

  • 89. CD19 can regulate B lymphocyte signal transduction independent of complement activation.
    Hasegawa M; Fujimoto M; Poe JC; Steeber DA; Tedder TF
    J Immunol; 2001 Sep; 167(6):3190-200. PubMed ID: 11544305
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Dynamics of microvesicle generation in B-cell chronic lymphocytic leukemia: implication in disease progression.
    Boysen J; Nelson M; Magzoub G; Maiti GP; Sinha S; Goswami M; Vesely SK; Shanafelt TD; Kay NE; Ghosh AK
    Leukemia; 2017 Feb; 31(2):350-360. PubMed ID: 27480387
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Enhanced Chemokine Receptor Recycling and Impaired S1P1 Expression Promote Leukemic Cell Infiltration of Lymph Nodes in Chronic Lymphocytic Leukemia.
    Patrussi L; Capitani N; Martini V; Pizzi M; Trimarco V; Frezzato F; Marino F; Semenzato G; Trentin L; Baldari CT
    Cancer Res; 2015 Oct; 75(19):4153-63. PubMed ID: 26282174
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
    Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
    Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Reduced expression of the complement receptor type 2 (CR2, CD21) by synovial fluid B and T lymphocytes.
    Illges H; Braun M; Peter HH; Melchers I
    Clin Exp Immunol; 2000 Nov; 122(2):270-6. PubMed ID: 11091285
    [TBL] [Abstract][Full Text] [Related]  

  • 94. CD5 and CD21 molecules are a functional unit in the cell/substrate adhesion of B-chronic lymphocytic leukemia cells.
    Bergui L; Tesio L; Schena M; Riva M; Malavasi F; Schulz T; Marchisio PC; Caligaris-Cappio F
    Eur J Immunol; 1988 Jan; 18(1):89-96. PubMed ID: 3278912
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Expression patterns of CD180 in the lymph nodes of patients with chronic lymphocytic leukaemia.
    Edwards K; Zaitseva K; Sayed U; Volpi EV; Nathwani A; Gribben JG; Lydyard P; Krysov S; Porakishvili N
    Br J Haematol; 2021 Oct; 195(2):e131-e134. PubMed ID: 34227107
    [No Abstract]   [Full Text] [Related]  

  • 96. A close-up on the expanding landscape of CD21-/low B cells in humans.
    Gjertsson I; McGrath S; Grimstad K; Jonsson CA; Camponeschi A; Thorarinsdottir K; Mårtensson IL
    Clin Exp Immunol; 2022 Dec; 210(3):217-229. PubMed ID: 36380692
    [TBL] [Abstract][Full Text] [Related]  

  • 97. A CD21 low phenotype, with no evidence of autoantibodies to complement proteins, is consistent with a poor prognosis in CLL.
    Nichols EM; Jones R; Watson R; Pepper CJ; Fegan C; Marchbank KJ
    Oncotarget; 2015 Oct; 6(32):32669-80. PubMed ID: 26452134
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Enhanced CD21 expression and shedding in chronic lymphatic leukemia: a possible pathomechanism in disease progression.
    Low HZ; Hilbrans D; Schmidt-Wolf IG; Illges H
    Int J Hematol; 2012 Sep; 96(3):350-6. PubMed ID: 22899340
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Phenotypic analysis of receptor-ligand pairs on B-cells in B-chronic lymphocytic leukemia.
    Gagro A; Dasić G; Sabioncello A; Rabatić S; Reckzeh B; Havemann K; Kardum I; Jacksić B; Vitale B
    Leuk Lymphoma; 1997 Apr; 25(3-4):301-11. PubMed ID: 9168440
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Quantitative expression of CD23 and its ligand CD21 in chronic lymphocytic leukemia.
    Lopez-Matas M; Rodriguez-Justo M; Morilla R; Catovsky D; Matutes E
    Haematologica; 2000 Nov; 85(11):1140-5. PubMed ID: 11064465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.